CP. i think thats pure conjecture as to why he left and do not believe that to be true. He is employed at another biotech in California. He could have stayed at pphm. Obviously made a decision to leave or was asked to leave.
Jeff Masten Vice President Technical Operations/Manufacturing at Atara Biotherapeutics Westlake Village, CaliforniaBiotechnology Previous Quality Consultant Biotechnology/Pharmaceutical Industry, Peregrine Pharmaceuticals, Genentech Education University of Notre Dame - Mendoza College of Business
With all due respect NOWHERE in my original post(my reply to The Other Guy) did I write "suddenly". Please do not post words that you may or may not ASSUME I meant. This response is exactly what I was referring to when I originally posted to TOG. If only certain posters are allowed to speculate or hypothesize this PPHM board is not very open to all avenues of discussion. IMO! PR
CP - I don't believe Masten left by his own decision. The 2014 proxy stated that he left and exercised all of his vested options, over 379K, however, if you look at the 2013 proxy, he had no where near that many options vested. Allowing all his options to vest must have been part of a separation agreement.
News 
Market Data 
Discover 
